Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission, Transgenomic said it plans to offer up to $3.5 million in common stock for sale on the Nasdaq and other trading markets.

Banking firm Craig-Hallum Capital Group will serve as sales manager, and will receive a commission of 3.25 percent based on the gross sales price, Transgenomic added. The shares will be offered at the prevailing market price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.